Condition: Intradialytic Hypotension · Intensive Care Unit ICU · Hemodialysis Patients · Sponsor: Chulalongkorn University
This single-center, crossover randomized controlled trial (HyPIR-ICU) investigates whether a Hypotension Prediction Index (HPI)-guided management strategy can reduce intradialytic hypotension (IDH) during prolonged intermittent renal replacement therapy (PIRRT) in critically ill patients. All participants must have an indwelling arterial catheter for continuous hemodynamic monitoring.
This description comes directly from the study's public registry record.
Nattapakorn Mai-on · 66970051116 · nattapakorn.m@gmail.com
Nuttha Lumlertgul · 66855788949 · nlumlertgul@gmail.com
Always discuss trial participation with your own doctor first.
| Division of Nephrology, Faculty of Medicine, Chulalongkorn University | Bangkok, Thailand | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07179705